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Abstract 
This study demonstrates the effect of active pharmaceutical ingredient (API) particle habit on the 
sticking propensity of ibuprofen.  Four diverse crystal habits with similar physico chemical properties 
are reported and the sticking propensity was found to increase with shape regularity.  The surface 
energy of the extreme habits were shown to be different where particles that were more regular in 
shape exhibited surface energies of 9 mJ/m2 higher than those that were needle-like in habit.  
Computational and experimental data reveals that the increase in surface energy of the regular 
shaped particles can be attributed to the increase in the specific (polar) component, which is due to 
greater presence of faces which contain the carboxylic acid functionality at the surface.  The increase 
in the specific energy component is shown to correlate with the sticking propensity of ibuprofen.  It is 
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proposed that investigation of the chemical causality of sticking, for this API and others, using the 
techniques demonstrated in this paper will be of increasing importance.  
 
Keywords: particle shape; surface energy; punch sticking; crystal chemistry 
1 Introduction 
During API development, critical quality attributes (CQAs) are set out in the final specifications for the 
drug product [1].  Solid form and particle size distributions are CQAs with particle shape and surface 
energy often neglected due to the lack of understanding of their impact.    
The engineering of particles with desired properties has become increasingly important and this has 
led to pharmaceutical Materials Science emerging as a foundation of Quality by Design (QbD) with 
solid form, crystallization and particle engineering being core elements linking the drug product 
functional form to the final steps of the API manufacturing process [2, 3].  More recently the 
importance of the Materials Science tetrahedron, depicting the relationships between internal 
structure, particle properties, material processing and performance of a drug product, has been 
described [4].  
For a given API the crystal habit is typically specified through the crystallisation protocol.  Different 
crystal faces of the API produced exhibit different surface chemistry and hence interact differently 
with solvents, process impurities and excipients.  These different crystal faces can be present in 
different proportions for a given API.  The changes in crystal habit, which are generally not controlled 
in specifications, in combination with particle size can lead to different chemical and physical 
stabilities, biopharmaceutical properties and processing behaviour (API and drug product) [5, 6]. 
This work seeks to outline some of the recent progress on the application of emerging computer 
modelling technologies for the design strategy of advanced functional particulate products [7].  The 
paper highlights the opportunity for bridging across the chemical, analytical and manufacturing 
disciplines with a particular focus on understanding punch sticking.   
One of the major issues affecting the production of pharmaceutical tablets is the formulation adhering 
to the tooling surfaces, known as punch sticking. Punch sticking compromises the manufacturing 
process. Many attempts in the literature have been made to determine the elusive root cause of this 
phenomenon however no single root cause has been identified [7, 8].  It is known that sticking may 
be due to API adherence even when it is present in a formulation at low concentrations [9] and many 
complex processing and environmental mechanisms such as speed/force/dwell time [10], 
temperature/humidity [11], punch geometry/quality where quality is defined as surface roughness 
and if the punch contains any defects[10] and lubrication [12] have been shown to contribute.   
There is still a lack of understanding between the particle habit and surface energy of an API and their 
role in punch sticking despite some recent efforts [ 7, 13].  One of the challenges often faced when 
trying to link these properties is punch sticking is not detected until full scale manufacture and there 
is a technology gap relating to a small scale test to predict sticking especially when APIs are limited in 
quantity.  This work presents a simple science of scale tool to quantify the sticking of an API with 
different particle habits and similar physico-chemical properties in combination with emerging 
computational tools to explore the crystal chemistry in relation to surface energies. 
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2 Materials and Methods  
2.1 Computational Tools 
This study focuses on racemic ibuprofen (RS)-ibuprofen.  The Cambridge Structural Database (CSD) 
was interrogated for (RS)-ibuprofen structures using ConQuest (CCDC 1.18, 2016).  The criteria for this 
search were R-factor of less than 0.0075 and no metals allowed.  The crystal structure selected for 
ibuprofen was IBPRAC and the carboxylic acid hydrogen bonding distance for this hit was measured 
and compared to all other hits with this functionality using the search criteria above. 
The .cif for IBPRAC, was imported into Materials Studio (v7.0, 2013) and the intermolecular 
interactions were calculated using the following force fields: geometry optimised/fractional charges 
assigned using COMPASS II/Tripos 5.2 force field, respectively [14, 15].  All further calculations were 
performed using these parameters.  HABIT98 [16, 17] was used to calculate the strength of the non-
bonded intermolecular interactions (intrinsic synthons) and lattice energy (Ecr).  In order to determine 
if the force field assigned accurately estimated the intermolecular strength of interactions the lattice 
energy was compared to the sublimation enthalpy (ΔHsub) as the relationship shown below exists: 
Ecr = ΔHsub – 2RT     (1) 
Where R is the gas constant and T is temperature. 
To further validate the force field, the strength of the most dominant intermolecular interaction was 
compared to validation work published by Dunitz and Gavezzotti [18].   
The Bravais, Friedel, Donnay and Harker (BFDH) [19-21] method was used to predict the most likely 
growth surfaces based on the rule which states the faces with the largest interplanar spacing (dhkl) are 
likely to be the most morphologically important at the surface [22, 23].  The lattice energy (Ecr) per 
surface was split into slice energy (Esl) and attachment energy (Eatt) based on the equation shown 
below [22] : 
Ecr = Esl + Eatt      (2) 
The morphology of ibuprofen was predicted using the attachment energy model which states that the 
faces with the lowest attachment energies will be the slowest growing and therefore be the most 
morphologically important [24]. 
Previously published studies have revealed that during crystallisation of ibuprofen only three of the 
surfaces predicted by the BFDH and attachment energy models are present [25-27].  These faces are 
{1 0 0}, {0 1 1} and {0 0 2} and Materials Studio was used to visualise the chemistry present at each 
surface (extrinsic synthons).   
The relative attachment energy of each face was expressed as centre to face distances then Mercury 
(CCDC 3.9, 2016) was used to visualise the external morphology.  The surface energy of these faces 
was calculated using the attachment energy calculation shown below [24]: 
𝛾ℎ𝑘𝑙 =  
𝑍𝐸𝑎𝑡𝑡𝑑ℎ𝑘𝑙
2𝑉𝑐𝑒𝑙𝑙𝑁𝐴
     (3) 
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Where Z is the numbers of molecules in the unit cell, Vcell is the unit cell volume, Eatt is the attachment 
energy, dhkl is the d spacing and NA is Avogadro’s number.  
The area of these faces was compared to scanning electron micrographs of two extreme ibuprofen 
habits and altered in Mercury (CCDC 3.9, 2016) to represent an average particle habit.  The fractional 
area of each face was expressed using Mercury then the particle surface energy was calculated by 
summing the face contribution to total surface energy based on area. 
2.2 Recrystallisation of ibuprofen  
(RS)-ibuprofen (40 µm grade, ≥99.8%) was supplied by Pfizer Ltd and was recrystallised from hexane 
(95%), toluene (>99.5%), acetonitrile (99.8%) and ethanol (>99.5%) purchased from Fisher Scientific 
(Loughborough, UK).  Supersaturated solutions were prepared at the following concentrations: 
hexane 1.1 g/mL, toluene 1.5 g/mL, acetonitrile 1.3 g/mL and ethanol 1.5 g/mL.  The solubility of 
ibuprofen in various solvents is documented in the following paper and was used a guide for these 
experiments [28].  These solutions were heated to 60°C in a jacketed Optimax reactor (Mettler Toledo, 
Leicester, UK).  The stirred solutions were cooled linearly at a rate of 1°C/min.  The solutions were 
seeded with 1% of starting material prior to nucleation and then further cooled linearly to 0°C at a 
rate of 1°C/min.  Product was obtained through filtering through general-purpose laboratory filter 
paper (Whatman, UK) and dried in an oven at 50°C for 24 hours.  The resultant batches were named 
according to their crystallisation solvent (i.e. IbuEth is ibuprofen crystallised from ethanol). 
2.3 Size and shape characterisation  
The recrystallised batches were sieved through a stainless steel sieve (Endecotts Ltd., London, UK) 
with a mesh size of 150 µm prior to characterisation. 
Scanning electron microscopy (SEM) was used to qualitatively assess particle morphology.  Electron 
micrographs were captured using a Zeiss SUPRA 40VP (Carl Zeiss Microscopy GmbH, Cambridge, UK).  
The samples were mounted onto an aluminium pin stub containing sticky carbon tabs and sputter 
coated with platinum.  A voltage of 3.0 kV and working distance of 10 mm were used. 
The particle size and shape of the samples were measured with a dynamic image analysis system 
QICPIC (Sympatec Ltd., Clausthal-Zellerfeld, Germany).  A vibratory feeder system (VIBRI, Sympatec) 
was combined with a dry air disperser (RODOS, Sympatec) and was operated at 0.5 bar pressure.  The 
system operates using a pulsed light source with sub-nanosecond illumination, and the particles were 
imaged by a high speed camera with a frame rate of 400 frames per second.  Single measurements 
were made using the M6 lens (measuring range of 5 – 1705 µm) and a minimum of 200,000 particles 
were imaged for each run.  Images were analysed using WINDOX (Sympatec) software with the size 
and shape distributions reported using the maximum Feret diameter in order to not lose valuable 
shape information. 
2.4 Physico-chemical characterisation 
Powder X-ray diffraction (PXRD) was performed by preparing the samples using a flat plate diffraction 
patterns collected on a D4 Endeavor (Bruker Corporation, Billerica, Massachusetts, USA).  The scan 
was carried out between 2° and 55° 2θ using CuKα radiation with a secondary graphite 
monochromator. 
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Differential scanning calorimetry (DSC) was performed in dry nitrogen gas using a Discovery DSC (TA 
Instruments – A division of Waters Ltd, Herts, UK). The DSC was calibrated using indium at heating 
rate of 10°C/min.  The samples (2.5 – 3 mg) were analysed in a T-zero standard pan at heating rate of 
10°C/min over the range from 30°C to 100°C.  Due to sample limitations only one measurement was 
made. 
Headspace gas chromatography (HS-GC) was performed using a 6892N Network GC system coupled 
to a 7694 HS sampler (Agilent Technologies, CA, US).  Around 20 mg of each sample was dissolved in 
N,N-dimethylacetamide (≥99%) purchased from Sigma Aldrich (Dorset, UK).  A liquid-vapour 
equilibrium was established by heating the solution in a sealed vial and an aliquot of the headspace 
vapour was analysed by capillary GC.  Quantification of each volatile impurity was achieved by 
comparison of the chromatographic peak areas of external reference standards with the peak areas 
of the test sample solutions. 
2.5 Sticking propensity  
The sticking propensity was measured using a Gamlen Tablet Press (GTP-1, Gamlen Tableting Limited, 
Nottingham, UK).  100 mg of sample was compacted in a 6 mm die at the following pressures:  40 
MPa, 120 MPa and 180 MPa at a speed of 60 mm/min.  A novel approach to quantify the amount of 
powder adhered to the base die was developed and is illustrated in Figure 1.  Prior to tablet ejection, 
the detachment stress of the base die was measured manually using a 50 kg hand held force gauge 
(Mecmesin, Slinfold, UK) placed at the side of the base die.  Detachment measurements were made 
in triplicate.  
2.6  Surface Analysis 
The specific surface area, pore size distributions and pore volume of the samples was measured using 
a TriStar II 3020 (Micromeritics U.K. Ltd., Hexton, UK).  Between 450 – 850 mg of sample was filled 
into 3/8’’ flat bottom cell with filler rods and conditioned under a helium purge at 40°C for 16 hours.  
Nitrogen isotherms were measured at -196°C.  The BET model [29] based on the linear region of the 
nitrogen adsorption isotherm (from p/p°=0.05 - 0.9) was used for data calculation.  Each batch was 
measured in duplicate. 
Surface energy heterogeneity was measured using inverse gas chromatography - surface energy 
analyser 2.0 (iGC-SEA, Surface Measurement Systems (SMS) Ltd., Alperton, UK).  The samples were 
packed into 4 mm pre-silanised glass columns and mechanically tapped for 10 minutes using SMS 
sample packing device.  All samples were packed to yield a total surface area of approximately 0.13 
m2.  The columns were pre-conditioned at 30°C and 0% RH using helium (carrier gas) at a flow rate of 
7 standard cubic centimetres per minute for 120 minutes and these conditions were maintained 
throughout the experiment duration.  A range of dispersive (non-polar) probes (decane, nonane, 
octane, heptane and hexane) and specific (polar) probes (ethyl acetate and chloroform) were injected 
at a range of surface coverages (n/nm) ranging from 1 to 20%; the column dead volume was 
determined using methane.  Data analysis was performed using the Cirrus Plus SEA Data Analysis 
software (v1.2, SMS Ltd., Alperton, UK).  The Dorris/Gray approach [30] was used to determine the 
dispersive energy contribution, whereas the specific energy contribution was determined by 
measuring the free energy desorption of a pair of mono-functional acidic and basic probes (chloroform 
and ethyl acetate), based on the polarisation approach [31] and Della Volpe scale [32].  Detailed 
reviews of these approaches can be found elsewhere [33, 34].  The repeatability and reproducibility 
of the iGC-SEA system is quoted by the manufacturer as RSD = 1% [35] which is lower than traditional 
6 
 
iGC techniques due to the system using the same pipe line and injection manifold for every injection 
[36].  To assess the instrument repeatability batch IbuEth was run in triplicate, but all other batches 
were run once due to limitations in availability of the iGC-SEA system. 
3 Results and Discussion  
3.1 Crystal Chemistry 
The molecular structure of ibuprofen consists of a phenyl ring with a propanoic acid group and isobutyl 
in the para position.  The structure can be further divided into four molecular components: A) isobutyl, 
B) phenyl, C) methyl attached to carbon backbone and D) carboxylic acid.  The unit cell, for the crystal 
structure of ibuprofen (IBPRAC), compromises of four molecules arranged in centro-symmetric 
hydrogen bonded dimers with dimensions a = 14.667 Ǻ, b = 7.886 Ǻ, c = 10.730 Ǻ and ß = 99.362° 
(Figure ).  The hydrogen bonding distance is 1.624 Ǻ.  This distance is slightly shorter than the mean 
value of the hits (1601) returned for carboxylic acid hydrogen bonding search in the Cambridge 
Structural Database (CSD), 1.743 Ǻ, which suggests that this interaction will be strong.    
3.1.1 Lattice Energy and Intrinsic Synthons 
The calculated lattice energy was -125.2 kJ/mol which is in excellent agreement with experimental 
sublimation enthalpies of 125.9 kJ/mol [26] and 115.9 kJ/mol [37].   
The different intrinsic synthon types were investigated and the six key interactions (>4 kJ/mol) are 
shown in Figure 3   A total of nine interactions compromising of six types make up 82% of the lattice 
energy, with the largest contribution coming from the carboxylic acid dimer with a value 
of -33.7 kJ/mol.  This was compared to Dunitz and Gavezzotti’s [18] value of -35 kJ/mol for these types 
of interactions which validates that the forcefield used has accurately predicted the strength of the 
interaction energy for this short hydrogen bonded dimer. 
The strength of this interaction is highlighted by comparing its contribution to lattice energy with the 
next strongest π-π stacking interaction which contributes 9% compared with 27%, a three-fold 
difference.  The five other interaction types are Van der Waals interactions and despite being crucial 
for the formation of the crystal are all relatively weak in comparison to the carboxylic acid dimers. 
The lattice energy was collapsed onto the individual atoms and summed across each molecular 
component and reveals that the strongest intermolecular synthon in the crystal structure is the H 
bonded carboxylic acid (molecular component D), with its contribution to the lattice energy of 37.5%.  
The molecular components can also be ranked in terms of their increasing contribution to the lattice 
energy: D>A>B>C  Figure 4. 
3.1.2 Ibuprofen Morphology Prediction 
The Bravais, Friedel, Donnay and Harker (BFDH) morphology of ibuprofen is shown in Figure a and 
reveals six predicted morphologically important faces.  The attachment energy morphology is shown 
in Figure b and reveals a flatter habit with the disappearance of faces {1 0 -2}, {0 1 1} and the 
appearance of {1 1 1}.  Although this morphology is similar to what is observed experimentally, 
literature reveals that the three dominant faces during crystallisation are {1 0 0}, {0 0 2} and {0 1 1} 
[25-27].  The first two faces are present in both the BDFH and attachment energy models however 
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face {0 1 1} is only present in the BDFH prediction.  The attachment energy model was altered to 
include the three faces present during crystallisation and this is shown in Figure c. 
3.1.3 Surface chemistry of ibuprofen 
Analysis of the three main faces reveals different crystal chemistry present at the surface of each, as 
shown in Figure 6 .  The dominant (1 0 0) face contains the aliphatic chains; group A at the surface 
with the molecules linked by the carboxylic acid dimers in the centre of the bulk.  This high energy 
interaction accounts for the directional growth of ibuprofen crystals in the [1 0 0] direction and is 
confirmed by the lath shaped particles usually produced during crystallisation from non-polar 
solvents, such as hexane [26].  The (0 1 1) and (0 0 2) face have the carboxylic acid group exposed at 
the surface allowing for potential hydrogen bonding to occur with Lewis bases.  This is confirmed by 
the habit change when polar crystallisation solvents, such as ethanol, are used and result in a plate 
like habit due to the slower growth of the (0 1 1) and (0 0 2) face [25, 26].  
 
It is evident from the different chemical functionalities present at each surface that the faces will 
exhibit different surface energies.  In order to view this qualitatively, colour coded images relating to 
the intrinsic synthon contribution to lattice energy for each surface are shown in Figure 7. 
Analysis of the dominant (1 0 0) face reveals that the extrinsic synthon exposed at this face is A.  This 
group is the aliphatic chain and both top and side views of this face show that the surface is flat with 
no exposure of the other synthons suggesting a relatively low surface energy.  Moving to face (0 0 2) 
the side view reveals that the molecules run at an angle in relation to the surface exposing extrinsic 
synthons C and D.  Synthon C is the lowest energy group however synthon D is the carboxylic acid 
group involved in the dimer meaning this has to be broken for exposure of this extrinsic synthon.  The 
top view of this face reveals that synthon D is slightly covered by synthon C but is still exposed at the 
surface.  On inspection of the side view of the (0 1 1) face it can be seen that the molecules run parallel 
to the surface exposing synthon A, C and D.  The top view of this face shows that the highest energy 
synthon (D) is fully exposed and forms channels which imply that this face has high energy due to the 
dimer not being fully saturated.  Qualitative analysis of the three faces ranks them in the following 
order of increasing surface energy (0 1 1) > (0 0 2) > (1 0 0).    
The surface energies of these faces were calculated and these predict the same trends from the 
qualitative analysis.  Face (1 0 0) exhibits the lowest surface energy of 30.7 mJ/m2.  Face (0 0 2) exhibits 
a higher surface energy of 47.1 mJ/m2 due to the slight exposure of Group D and the full exposure of 
this group increases the surface energy of face (0 1 1) to 73.8 mJ/m2. 
The particle surface energies of the two extreme habits of ibuprofen can be compared, where it can 
be seen that particles crystallised from polar solvents (e.g. ethanol) which contain a more regular habit 
exhibit a higher particle surface energy ~48.4 mJ/m2 than the surface energy of needle-like habit 
crystallised from non-polar solvents (e.g. hexane) ~38.8 mJ/m2.  These predictions are in agreement 
with the expected results that an increase in solvent polarity increases the fractional surface coverage 
of the higher energy faces and in turn results in a larger particle surface energy. 
3.2 Size and shape characterisation of recrystallised batches  
Scanning electron micrographs for recrystallised batches are shown in Figure  where differences in 
particle habit are observed.  As expected, increasing the solvent polarity 
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(hexane<toluene<acetonitrile<ethanol) increases the shape regularity such that the particles change 
from needle/lath shaped particles to plate/prismatic shaped.   
Particle size and shape analysis (QICPIC) was performed on all batches and the number weighted 
distributions (most sensitive to smaller particles in the sample) are shown in Figure a and the volume 
weighted distributions (most sensitive to the large particles in the sample) are shown in Figure b.  It 
should be noted that although the batches were passed through a 150 µm sieve they all contain a 
proportion of particles greater than this.  This is due to elongated particles passing through the mesh 
along their shortest axis and also reporting the data using Feret Max.   IbuAce contains the highest 
proportion of fine (~5 µm) particles and the lowest proportion of coarse material (50 – 400 µm).  The 
volume distribution for this batch is observed to be centered ~250 microns which is higher than all 
other batches (centered at ~125 µm), inferring that this batch has the widest size distribution.  All 
other batches contain a similar proportion of particles by number and have primary modes centering 
around 125 µm by volume.  
The aspect ratio (width/length) versus particle size (40 - 400 µm) of the batches is shown in Error! 
Reference source not found. and ranks the batches as follows in terms of decreasing aspect ratio 
ethanol > acetonitrile > toluene > hexane.  This data confirms the visual observation that increasing 
solvent polarity in turn increases shape regularity.   
3.3 Physico-chemical characterisation 
It was expected that no form change, from (RS)-ibuprofen form I, would occur during the 
recrystallisation of ibuprofen as the only other form reported, form II [38], was prepared by annealing.  
PXRD was performed to confirm this result.  The diffraction patterns for the recrystallised batches are 
shown in Figure  and reveal that all peaks are aligned.  Perhaps not unexpectedly, there is some impact 
on the PXRD intensities due to the texture of the samples.  Some preferred orientation is seen in Figure 
10 especially from needles crystallised from hexane (a).  From the single crystal data it is known where 
every major peak for form I should be and all the PXRD patterns in Figure 10 are consistent with that.  
The DSC data (Figure 11) also shows all four samples are form I.  This data confirms that no form 
change has occurred during the recrystallisation and that the form present is (RS)-ibuprofen form I 
due to the mild crystallisation conditions. 
The DSC thermograms for all samples are shown in Figure  and reveal no major differences between 
the melt of the samples.  The onset of the melt was extrapolated using Trios software (TA Instruments 
– A division of Waters Ltd, Herts, UK) and was shown to be similar for all samples, with the range 73.7 
- 74.5°C.  The peak melting temperatures were found to be within the range 75.8 – 76.1°C,  again 
confirming that no form changes had occurred during recrystallisation and all samples are of similar 
crystallinity.  The enthalpy of fusion values for recrystallised ibuprofen batches were shown to be; 
123.2 J/g for hexane, 126.8 J/g for toluene, 127.4 J/g for acetonitrile and 118.6 J/g for ethanol.  It can 
be seen that there is some variation between the samples, however they are all form I as the reported 
enthalpy of fusion for form II is 33.9 J/g and unstable at room temperature [38]. 
The respective volatile organic solvent for each recrystallised batch were quantified using HS-GC and 
the resultant residual solvent levels are shown to be low (≤180 PPM) and are below the maximum 
acceptable daily exposure guidelines, as set be ICH Q3C (R6) 2016.  
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3.4 Sticking Propensity  
The sticking propensity of the batches was measured by recording the detachment stress from the 
base die post compaction.  It is proposed that higher stresses relate to more powder adhering to the 
die in turn inferring a greater sticking propensity.  The detachment stress measurements at 3 
compaction pressures are shown in Table 1.  At the lowest compaction pressures all samples exhibit 
no sticking and low detachment stress readings (≤0.1 MPa).  As the pressure increases the detachment 
stress values diverge and the largest difference is observed at the highest compaction pressure (~180 
MPa) where batches can be ranked as follows in terms of sticking propensity: 
IbuHex<IbuTol<IbuAce<IbuEth.  When sticking is observed the standard deviations of the 
measurements generally increase and large variation is observed at 108 MPa for IbuEth however the 
sticking trend is still clear.  From this it can be concluded that the sticking propensity of the batches 
can be ranked in terms of particle habit with an increase in aspect ratio resulting in an increase in 
sticking propensity 
3.5 Surface Analysis 
The BET surface area values are presented in Table 2 and show that despite the change in crystal habit 
the surface area of the particles remains similar, with values between 0.082 - 0.109 m2/g.  The 
cumulative pore area and volume are also shown in Table 2, where no correlation with sticking 
propensity can be observed.  
Typical isotherms for all batches, as shown in Figure 12, classify all batches as Type II: non-porous or 
macroporous according to the IUPAC guidelines [39].  These results suggest that surface area and pore 
size are not contributing factors to the observed differences in the sticking propensity of the different 
habits.   
Surface energy heterogenity was calculated for all batches and split into total and dispersive/specific 
contributions.  Studies have suggested surface energy values close to ‘infinite dilution’ should be 
reported due to the high energy sites being analysed and hence these values being representative of 
the entire material surface properties [36].  In order to achieve this, energy values are typically 
reported at surface coverages of <5%.   
The total surface energy (γt) is shown in Table 3 and reveals that the batches IbuAce, IbuTol and IbuHex 
would rank differently depending on what surface coverage value below 5% was reported.  Despite 
this it is clear that batch IbuEth exhibits the highest total surface energy at all analysed surface 
coverages (at 1% surface coverage IbuEth has a total surface energy of 67.3 mJ/m2  whereas all other 
batches exhibit lower values between 61.1 – 62.0 mJ/m2).   
The same trends are seen from the specific surface energy (γab) values, Table 3, where IbuEth exhibits 
a higher specific component at all surface coverages compared to all other batches (at 1% surface 
coverage batch IbuEth has a specific surface energy of 26.4 mJ/m2  whereas all other batches exhibit 
lower values between 20.7 – 20.8 mJ/m2).  These results agree with the computational work described 
where crystallisation in a polar solvent (e.g. ethanol) results in particles with a higher aspect ratio due 
to the greater exposure of the (0 0 2) and (0 1 1) faces.  These faces contain a higher surface energy 
due to the presence of the carboxylic acid groups at the surface and in turn increase the specific 
surface energy.   
At surface coverages below 5% the dispersive surface energy for all batches was similar, with values 
between 40.3 – 41.8 .7 mJ/m2.  The dispersive surface energy was unable to be ranked and reveals 
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that the changes in the total surface energy are due to to the variations in specific surface energy only.  
This implys that the proportion of the main (1 0 0) face stays constant during particle growth and only 
the proportion of the (0 0 2) and (0 1 1) face are altered when the polarity of the crystallisation solvent 
is increased.    
It would be expected that the total surface surface energy (influenced by the specific surface energy) 
would decrease as the aspect ratio of particles decreases.  These trends are not observed for IbuAce, 
IbuHex and IbuTol and these batches would be ranked the same if error is accounted for.  This could 
be due to instrument sensitiviy however an increase in specific surface energy as aspect ratio increases 
can be inferred from the computational work.  Batch IbuEth contains the highest specific surface 
energy and exhibits the highest sticking propensity.  If the findings from the computational work are 
taken into acount then sticking propensity increases as specific surface energy increases.  Previous 
work has shown that a higher surface energy leads to greater cohesion therefore a higher tensile 
strength of tablets [40].  The findings from this study suggest that the specific contribution to the total 
surface energy may alter the adhesive properties and a higher specific component leads to greater 
adhesion and therefore sticking propensity.  
It should be noted here that the computational data is derived from a bottom-up approach where the 
energy is calculated from the unsaturated interactions at the surface of the face.  The iGC data is based 
on a top-down approach where the energy is derived from interactions at the surface from the highest 
energy sites.  In order to compare the two techniques caution must be taken when reporting iGC data 
due to different surface coverages.  It is proposed that as computational modelling accounts for the 
whole surface and not just high energy sites then reporting iGC at infinite dilution would not be 
suitable for this comparison.  The total surface energy (at 20% surface coverage) for needles is 56.0 
mJ/m2 compared to 65.1 mJ/2 for prisms.  This is a 9.1 mJ/m2 increase for the prisms compared to 
the needles and the calculated surface energy reveals a similar increase of 9.6 mJ/2 (needles: 38.8 
mJ/m2 and prisms: 48.4 mJ/m2).  These values are not alingned due to the differences in the 
approaches descirved above however do show excellent agreement in the differences. 
4 Conclusion 
The crystal chemistry of ibuprofen was explored and the importance of the hydrogen bonded 
carboxylic acid dimers contribution to lattice energy was revealed.  The surface chemistry of the three 
dominant faces was visualised in relation to lattice energy and the calculated surface energy values of 
the faces increased as the exposure of the carboxylic acid group increased.      
The different surface chemistries enabled the proportion of each face to be altered by crystallisation 
in solvents with differing polarity and ibuprofen was successfully crystallised into four diverse particle 
habits.  The sticking propensity of these batches was shown to be driven by the changes in particle 
habit, where a more regular particle habit resulted in the material demonstrating a higher degree of 
sticking.  To further investigate if the sticking propensity was driven by a chemical change altered by 
the difference in physical shape the surface energy of particles was explored.   
The particle surface energies of the extreme habits were compared experimentally by iGC and 
computationally.  Although the absolute values did not align both approaches showed that prism 
shaped particles exhibited a higher energy of around 9 mJ/m2 compared to needles.  The iGC and 
qualitative modelling data further revealed this difference to be attributed to the increase in the 
specific (polar) component, which is due to greater presence of faces which contain the carboxylic acid 
functionality at the surface.   
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The combination of experimental and computational surface energy techniques reveal that the 
sticking propensity of ibuprofen is increased by a change in specific surface energy caused by a change 
in crystal habit.  Computational and experimental data reveals that the increase in surface energy of 
the regular shaped particles can be attributed to the increase in the specific (polar) component, which 
is due to greater presence of faces which contain the carboxylic acid functionality at the surface.  The 
increase in the specific energy component is shown to correlate with the sticking propensity of 
ibuprofen.  It is proposed that investigation of the chemical causality of sticking, for this API and others, 
using the techniques demonstrated in this paper will be of increasing importance.  
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Figure 1 – Gamlen Tablet Press detachment force tool used for the quantification of sticking 
propensity. 
 
 
Figure 2 –Ibuprofen unit cell displaying hydrogen bonded carboxylic acid dimers. 
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Figure 3 – Key interaction types and their energy contribution to the total lattice energy.  
 
 
Figure 4 – Energy diagram of the lattice energy contribution from atoms and overall contribution 
from molecular components.  
 
a) 
 
b) 
 
c) 
 
Figure 5 –Predicted morphology of ibuprofen where a) BFDH highlighting six morphologically 
important crystal faces b) attachment energy morphology highlighting five morphologically 
important crystal faces c) attachment energy morphology edited to only include the three faces 
observed during crystallisation. 
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Ibuprofen dominant surfaces 
(1 0 0) (0 1 1) (0 0 2) 
 
 
 
 
Figure 6 – Crystal chemistry of ibuprofen dominant surfaces. 
 
 
a) side view b) top view 
 
 
 
Figure 7 – Crystal chemistry of ibuprofen surfaces colour coded related to the atomic contribution 
to lattice energy a) side view of the three faces b) top view of the three faces. 
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a) 
 
b) 
 
 
c) 
 
d) 
 
 
Figure 8 – Scanning electron micrographs of recrystallised ibuprofen showing changes in particle 
habit from; a) hexane b) toluene c) acetonitrile d) ethanol.  All images captured using x100 
magnification and scale bar is 100 µm.  
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a) 
 
b) 
 
c) 
 
     
Figure 9 – QICPIC a) number and b) volume weighted distributions for recrystallised ibuprofen 
batches;  c) QICPIC aspect ratio versus particle size for recrystallised batches. 
 
 
Figure 10 – Powder X-ray diffraction patterns for recrystallised ibuprofen a) hexane b) toluene 
c) ethanol d) acetonitrile. 
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Figure 11 – DSC thermograms of recrystallised ibuprofen a) ethanol b) toluene c) acetonitrile d) 
hexane.    
 
a) 
 
b) 
 
c) 
 
d) 
 
Figure 12 – Typical isotherms for recrystallised ibuprofen batches a) IbuHex b) IbuTol c) IbuAce 
d) IbuEth 
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Table 1 – Detachment stress of recrystallised ibuprofen at three compaction pressures.  Standard 
deviation of three measurements are shown in brackets. 
 Detachment Stress 
Batch 40 MPa 108 MPa 180 MPa 
IbuHex 0.05 (0.01) 0.08 (0.01) 0.50 (0.01) 
IbuTol 0.09 (0.02) 0.27 (0.03) 0.72 (0.22) 
IbuAce 0.07 (0.01) 0.63 (0.10) 1.97 (0.39) 
IbuEth 0.10 (0.01) 3.38 (0.96) 3.37 (0.24) 
 
Table 2 – BET surface area, cumulative pore volume and cumulative pore area for recrystallised 
ibuprofen samples.  Reported values are mean of two measurements. 
Batch BET surface area (m2/g) Cumulative pore volume 
(mm3/g) 
Cumulative pore area (m2/g) 
IbuHex 0.109 0.183  0.114  
IbuTol 0.082 0.111  0.070  
IbuAce 0.101 0.095 0.054  
IbuEth 0.082  0.153 0.074 
 
Table 3 – Surface energy (total γt and specific γab) for recrystallised ibuprofen at different surface 
coverages.  Reported standard deviation shown in brackets is of three measurements made on 
sample with highest variation in surface energy (IbuEth). 
 Surface energy (mJ/m2) 
 IbuHex IbuTol IbuAce IbuEth 
Surface 
coverage 
γt γab γt γab γt γab γt γab 
1 62.0 20.7 61.9 20.8 61.1 20.7 67.3 
(2.4) 
26.4 
(1.7) 
2 60.7 20.1 62.9 21.2 62.1 20.8 67.0 
(2.1) 
26.2 
(1.6) 
4 60.9 20.2 59.3 19.0 62.0 20.2 66.6 
(1.9) 
25.9 
(1.5) 
6 60.0 19.8 59.1 18.6 57.4 17.7 66.3 
(2.0) 
25.8 
(1.5) 
10 57.5 18.8 55.0 16.1 53.5 15.5 65.8 
(1.8) 
25.5 
(1.5) 
15 56.4 18.3 56.2 16.7 52.1 14.6 65.4 
(1.8) 
25.3 
(1.5) 
20 56.0 18.1 54.9 15.4 50.6 13.8 65.1 
(1.5) 
25.1 
(1.3) 
 
